These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3451957)

  • 41. Drug interaction between sunitinib and cimetidine and contribution of the efflux transporter ATP-binding cassette C2 to biliary excretion of sunitinib in rats.
    Arakawa-Todo M; Ueyama J; Nomura H; Abe F; Tsukiyama I; Matsuura K; Hasegawa T
    Anticancer Res; 2013 Aug; 33(8):3105-11. PubMed ID: 23898066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phosphatidylserine as a determinant for the tissue distribution of weakly basic drugs in rats.
    Yata N; Toyoda T; Murakami T; Nishiura A; Higashi Y
    Pharm Res; 1990 Oct; 7(10):1019-25. PubMed ID: 2281030
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of quinidine, cimetidine, and ketoconazole on the enantioselective pharmacokinetics and metabolism of metoprolol in rats.
    Boralli VB; Coelho EB; Lanchote VL
    Chirality; 2009 Nov; 21(10):886-93. PubMed ID: 19161215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males.
    Karbwang J; Davis TM; Looareesuwan S; Molunto P; Bunnag D; White NJ
    Br J Clin Pharmacol; 1993 Mar; 35(3):265-71. PubMed ID: 8471402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mexiletine kinetics in healthy subjects taking cimetidine.
    Klein A; Sami M; Selinger K
    Clin Pharmacol Ther; 1985 Jun; 37(6):669-73. PubMed ID: 4006366
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pharmacokinetics and organ distribution of ajmaline and quindine in the mouse.
    Iven H
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):43-50. PubMed ID: 882146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of antipyrine metabolite formation. Steady state studies with cimetidine and metyrapone in rats.
    Shaw PN; Tseti J; Warburton S; Adedoyin A; Houston JB
    Drug Metab Dispos; 1986; 14(2):271-6. PubMed ID: 2870906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in steady state digoxin pharmacokinetics during quinidine therapy in cardiac patients: influence of plasma quinidine concentration.
    Pedersen KE; Christiansen BD; Klitgaard NA; Nielsen-Kudsk F
    Acta Pharmacol Toxicol (Copenh); 1983 May; 52(5):357-63. PubMed ID: 6880771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative study of increased plasma quinidine concentration in rats with glycerol- and cisplatin-induced acute renal failure.
    Izuwa Y; Kusaba J; Horiuchi M; Aiba T; Kawasaki H; Kurosaki Y
    Drug Metab Pharmacokinet; 2009; 24(5):451-7. PubMed ID: 19881257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of the ORM1 phenotypes on serum unbound concentration and protein binding of quinidine.
    Li JH; Xu JQ; Cao XM; Ni L; Li Y; Zhuang YY; Gong JB
    Clin Chim Acta; 2002 Mar; 317(1-2):85-92. PubMed ID: 11814462
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical pharmacokinetics of cimetidine.
    Somogyi A; Gugler R
    Clin Pharmacokinet; 1983; 8(6):463-95. PubMed ID: 6418428
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical oral doses of dexamethasone decreases intrinsic clearance of quinidine, a cytochrome P450 3A substrate in dogs.
    Zhang K; Kohno S; Kuroha M; Kokue E; Shimoda M
    J Vet Med Sci; 2006 Sep; 68(9):903-7. PubMed ID: 17019057
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cigarette smoking and theophylline metabolism: effects of cimetidine.
    Cusack BJ; Dawson GW; Mercer GD; Vestal RE
    Clin Pharmacol Ther; 1985 Mar; 37(3):330-6. PubMed ID: 3971657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cimetidine versus famotidine: the effect on the pharmacokinetics of theophylline in rats.
    Mojaverian P; Rocci ML; Saccar CL; Vlasses PH; Ferguson RK
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):155-9. PubMed ID: 2864251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of carbamazepine metabolism by cimetidine.
    Grasela DM; Rocci ML
    Drug Metab Dispos; 1984; 12(2):204-8. PubMed ID: 6144486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat.
    Klecker RW; Jamis-Dow CA; Egorin MJ; Erkmen K; Parker RJ; Stevens R; Collins JM
    Drug Metab Dispos; 1994; 22(2):254-8. PubMed ID: 7912177
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-tissue distribution relationship based on physiological pharmacokinetics for NY-198, a new antimicrobial agent, and the related pyridonecarboxylic acids.
    Okezaki E; Terasaki T; Nakamura M; Nagata O; Kato H; Tsuji A
    Drug Metab Dispos; 1988; 16(6):865-74. PubMed ID: 2907467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disposition kinetics of dihydroquinidine following quinidine administration.
    Ueda CT; Williamson BJ; Dzindzio BS
    Res Commun Chem Pathol Pharmacol; 1976 Jun; 14(2):215-25. PubMed ID: 940955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics and pharmacodynamics of quinidine and its metabolite, quinidine-N-oxide, in beagle dogs.
    Rakhit A; Guentert TW; Holford NH; Verhoeven J; Riegelman S
    Eur J Drug Metab Pharmacokinet; 1984; 9(4):315-24. PubMed ID: 6532805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of pentoxifylline clearance by cimetidine.
    Luke DR; Rocci ML; Hoholick C
    J Pharm Sci; 1986 Feb; 75(2):155-7. PubMed ID: 3958924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.